These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 1568172)

  • 41. Rare case of neglected pessary presenting with concealed vaginal hemorrhage.
    Andrikopoulou M; Lazarou G
    Female Pelvic Med Reconstr Surg; 2015; 21(1):e1-2. PubMed ID: 25185620
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Levator ani muscle avulsion is a risk factor for expulsion within 1 year of vaginal pessary placed for pelvic organ prolapse.
    Cheung RYK; Lee JHS; Lee LL; Chung TKH; Chan SSC
    Ultrasound Obstet Gynecol; 2017 Dec; 50(6):776-780. PubMed ID: 28078670
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Clinical analysis of 20 patients with vaginal intraepithelial neoplasia].
    Li SM; Zhang WH; Bai P; Li HJ; Zhang R; Wu LY
    Zhonghua Fu Chan Ke Za Zhi; 2009 Apr; 44(4):277-80. PubMed ID: 19570466
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Vaginal cancer: the role of infectious and environmental factors.
    Merino MJ
    Am J Obstet Gynecol; 1991 Oct; 165(4 Pt 2):1255-62. PubMed ID: 1659200
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Vaginal pessaries and their use in pelvic relaxation.
    Sulak PJ; Kuehl TJ; Shull BL
    J Reprod Med; 1993 Dec; 38(12):919-23. PubMed ID: 8120847
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of Cervical Pessary on Spontaneous Preterm Birth in Women With Singleton Pregnancies and Short Cervical Length: A Randomized Clinical Trial.
    Saccone G; Maruotti GM; Giudicepietro A; Martinelli P;
    JAMA; 2017 Dec; 318(23):2317-2324. PubMed ID: 29260226
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Vaginal Pessary in Women With Symptomatic Pelvic Organ Prolapse: A Randomized Controlled Trial.
    Cheung RY; Lee JH; Lee LL; Chung TK; Chan SS
    Obstet Gynecol; 2016 Jul; 128(1):73-80. PubMed ID: 27275798
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Optimizing Local Control in High-Grade Uterine Sarcoma: Adjuvant Vaginal Vault Brachytherapy as Part of a Multimodal Treatment.
    Annede P; Gouy S; Mazeron R; Bentivegna E; Maroun P; Petit C; Dumas I; Leary A; Genestie C; Lhommé C; Deutsch E; Morice P; Pautier P; Haie-Meder C; Chargari C
    Oncologist; 2017 Feb; 22(2):182-188. PubMed ID: 28174295
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Results and problems in the management of vaginal carcinoma (1944-1963)].
    Buchheim CE
    Radiol Clin Biol; 1970; 39(5):427-33. PubMed ID: 5506486
    [No Abstract]   [Full Text] [Related]  

  • 50. Factors Affecting Successfulness of Vaginal Pessary Use for the Treatment of Pelvic Organ Prolapse.
    Lekskulchai O; Wanichsetakul P
    J Med Assoc Thai; 2015 Apr; 98 Suppl 3():S115-20. PubMed ID: 26387398
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Treatment of late recurrent vaginal malignancy after initial radiotherapy for carcinoma of the cervix: an analysis of 73 cases.
    Xiang-E W; Shu-mo C; Ya-qin D; Ke W
    Gynecol Oncol; 1998 May; 69(2):125-9. PubMed ID: 9600819
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Successful pregnancy with the use of vaginal pessary in a patient with a very short cervix. A case report.
    Louras GM; Tzifa GM; Hatziveis KM
    Clin Ter; 2014; 165(6):299-301. PubMed ID: 25524185
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Postoperative external beam irradiation with and without brachytherapy in pelvic node-positive IB1-IIA2 cervical cancer patients: a retrospective clinical study.
    Li L; Kou X; Feng X; Zhang M; Chao H; Wang L
    Radiat Oncol; 2015 Sep; 10():189. PubMed ID: 26377326
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prognostic factors for curative pelvic exenterations in patients with recurrent uterine cervical or vaginal cancer.
    Sardain H; Lavoué V; Laviolle B; Henno S; Foucher F; Levêque J
    Int J Gynecol Cancer; 2014 Nov; 24(9):1679-85. PubMed ID: 25254565
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Carcinoma in situ of the vagina.
    Hummer WK; Mussey E; Decker DG; Dockerty MB
    Am J Obstet Gynecol; 1970 Dec; 108(7):1109-16. PubMed ID: 5479689
    [No Abstract]   [Full Text] [Related]  

  • 56. [First year experience using arabin cervical pessary with intravaginal micronized progesterone for the prevention of preterm birth in patients with mid-trimester short cervix].
    Zimerman AL; Neeman O; Wiener Y; Maymon R; Arie H
    Harefuah; 2014 Feb; 153(2):79-82, 127. PubMed ID: 24716423
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pessary use in advanced pelvic organ prolapse.
    Powers K; Lazarou G; Wang A; LaCombe J; Bensinger G; Greston WM; Mikhail MS
    Int Urogynecol J Pelvic Floor Dysfunct; 2006 Feb; 17(2):160-4. PubMed ID: 15883856
    [TBL] [Abstract][Full Text] [Related]  

  • 58. High dose-rate intracavitary brachytherapy for cervical carcinomas with lower vaginal infiltration.
    Kazumoto T; Kato S; Tabushi K; Kutsutani-Nakamura Y; Mizuno H; Takahashi M; Shiromizu K; Saito Y
    Int J Radiat Oncol Biol Phys; 2007 Nov; 69(4):1157-66. PubMed ID: 17459604
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A Clinical Evaluation of American Brachytherapy Society Consensus Guideline for Bulky Vaginal Mass in Gynecological Cancer.
    Murofushi KN; Kitamura N; Yoshioka Y; Sumi M; Ishikawa H; Oguchi M; Sakurai H
    Int J Gynecol Cancer; 2018 Sep; 28(7):1438-1445. PubMed ID: 30044320
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Carcinoma of the vagina. Factors influencing treatment outcome.
    Peters WA; Kumar NB; Morley GW
    Cancer; 1985 Feb; 55(4):892-7. PubMed ID: 3967181
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.